Kitamura K, Beppu R, Anai H, Ikejiri K, Yakabe S, Sugimachi K, et al. Clinicopathologic study of patients with Borrmann type IV gastric carcinoma. J Surg Oncol. 1995;58(2):112–7.

Article  CAS  PubMed  Google Scholar 

Kodera Y, Ito S, Mochizuki Y, Yamamura Y, Misawa K, Ohashi N, et al. The number of metastatic lymph nodes is a signifcant risk factor for bone metastasis and poor outcome after surgery for linitis plastica-type gastric carcinoma. World J Surg. 2008;32(9):2015–20.

Article  PubMed  Google Scholar 

Aranha GV, Georgen R. Gastric linitis plastica is not a surgical disease. Surgery. 1989;106(4):758–62.

CAS  PubMed  Google Scholar 

Japanese Gastric Cancer Association. Gastric Cancer Treatment Guidelines 2021 (6th edition). Gastric Cancer. 2021;26(1):1–25.

Sano T, Sasako M, Mizusawa J, Yamamoto S, Katai H, Yoshikawa T, et al. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma. Ann Surg. 2017;265(2):277–83.

Article  PubMed  Google Scholar 

Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810–20.

Article  CAS  PubMed  Google Scholar 

Hayashi T, Yoshikawa T, Kamiya A, Date K, Wada T, et al. Is splenectomy for dissecting splenic hilar lymph nodes justified for scirrhous gastric cancer? Gastric Cancer. 2020;23(5):922–6.

Article  PubMed  Google Scholar 

Iwasaki Y, Terashima M, Mizusawa J, Katayama H, Nakamura K, et al. Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial. Gastric Cancer. 2021;24(2):492–502.

Article  CAS  PubMed  Google Scholar 

Brierley JD, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumors. 8th ed. Hoboken, New Jersey: Wiley-Blackwell; 2017. p. 63–6.

Google Scholar 

Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101–12.

Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82(3):346–51.

Article  CAS  PubMed  Google Scholar 

Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8.

Article  CAS  PubMed  Google Scholar 

Yamagata Y, Yoshikawa T, Ishizu K, Tsutsui M, Wada T, et al. Impact of D2 gastrectomy for locally advanced gastric cancer in the era of effective adjuvant chemotherapy. World J Surg. 2023;47(6):1512–8.

Article  PubMed  Google Scholar 

Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29(33):4387–93.

Article  CAS  PubMed  Google Scholar 

Nakazawa N, Sohda M, Yamaguchi A, Watanabe T, Saito H, et al. Preoperative risk factors and prognostic impact of postoperative complications associated with total gastrectomy. Digestion. 2022;103(6):397–403.

Article  CAS  PubMed  Google Scholar 

Wang S, Xu L, Wang Q, Li J, Bai B, et al. Postoperative complications and prognosis after radical gastrectomy for gastric cancer: a systematic review and meta-analysis of observational studies. World J Surg Oncol. 2019;17(1):52. https://doi.org/10.1186/s12957-019-1593-9.

Article  PubMed  PubMed Central  Google Scholar 

Ichikawa D. Surgery with minimal bleeding. Ann Gastroenterol Surg. 2024;8(1):6–7.

Article  PubMed  PubMed Central  Google Scholar